Pfizer Inc.

NYSE:PFE

Drug Manufacturers - General

Healthcare
$28.06 -2.72%

-$0.71 today

Market cap
$159.94B
Beta
0.29
P/E (TTM)
19.2
EPS (TTM)
$1.32
Dividend yield
6.82%
52W Low $23.11High $28.75

Volume 37.37M

Average 36.66M

PFE Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Pfizer Inc.NYSE: PFE

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 5.7B shares rose 0.2% year over year, in line with the +0.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.1% from the prior quarter. Over 3 fiscal years it compounded at +0.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.2% toward the trailing-twelve-month pace of +0.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
5.7B+0.1% QoQ
Last fiscal yearDec 2025
5.68B+0.3% YoY
LTMJun 2026
5.69B+0.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.2%——
1 year+0.3%——
3-year CAGR+0.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
5.68B USD
Year-over-year change
+0.3%
4-year CAGR
+0.4%

Weighted Avg Shares vs competitors

How PFE compares with its peers on the latest reported figures

  • PFE's LTM Jun 2026 weighted avg shares of 5.69B shares is the highest of the 11 companies compared; the peer median is 1.96B shares.
  • Its year-over-year change of +0.3% is the 3rd highest of 11, against a peer median of -0.3%.
  • Over three fiscal years its annual growth of +0.4% compares with a peer median of -0.6%.
PFE Competitors Peer median
Weighted Avg Shares for PFE and competitors
Company Period LTM YoY 3-year CAGR
PFEPfizer Inc.LTM Jun 20265.69B +0.3%+0.4%
MRKMerck & Co., Inc.LTM Jun 20262.48B -2.0%-0.4%
JNJJohnson & JohnsonLTM Sep 20262.44B +1.0%-2.4%
SNYSanofiLTM Jun 20262.42B -2.7%-0.8%
BMYBristol-Myers Squibb CompanyLTM Jun 20262.04B +0.5%-1.4%
GSKGSK plcLTM Jun 20262.01B -1.4%+0.2%
NVSNovartis AGLTM Jun 20261.91B -3.3%-3.8%
ABBVAbbVie Inc.LTM Sep 20261.77B +0.1%+0.1%
AZNAstraZeneca PLCLTM Sep 20261.55B -0.2%+0.0%
GILDGilead Sciences, Inc.LTM Jun 20261.24B -0.3%-0.3%
LLYEli Lilly and CompanyLTM Jun 2026895.45M -0.4%-1.9%
Peer median (excluding PFE) 1.96B-0.3%-0.6%

Competitors are the stored peer set for PFE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue81.29B101.18B59.55B63.63B62.58B
Cost of Revenue30.82B34.34B24.95B17.85B16.07B
Gross Profit50.47B66.83B34.6B45.78B46.51B
Gross Margin62.1%66.1%58.1%71.9%74.3%
Research & Development13.83B11.43B10.68B10.82B10.44B
Selling, General & Admin12.7B13.68B14.77B14.73B13.79B
Operating Expenses30.23B28.71B30.18B30.84B29.11B
Depreciation & Amortization5.19B5.06B6.29B7.01B6.59B
EBITDA30.79B41.03B9.56B18.13B16.78B
EBITDA Margin37.9%40.6%16.0%28.5%26.8%
Operating Income20.24B38.12B4.42B14.94B17.41B
Operating Margin24.9%37.7%7.4%23.5%27.8%
Interest Income36M251M1.62B545M603M
Interest Expense1.29B1.24B2.21B3.09B2.67B
Other Income / Expenses4.08B(3.39B)(3.36B)(6.92B)(9.89B)
Income Before Tax24.31B34.73B1.06B8.02B7.52B
Pre-Tax Margin29.9%34.3%1.8%12.6%12.0%
Income Tax Expense1.85B3.33B(1.12B)(28M)(266M)
Net Income21.98B31.37B2.12B8.03B7.77B
Net Margin27.0%31.0%3.6%12.6%12.4%
EPS (Basic)3.955.590.381.421.36
EPS (Diluted)3.885.470.371.411.36
Weighted Avg Shares5.6B5.61B5.64B5.66B5.68B
Weighted Avg Shares (Diluted)5.71B5.73B5.71B5.7B5.69B

Pfizer Inc.

NYSE:PFE

Intrinsic Alpha fair value

Locked

Current Price

$28.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.